HDAC2 and TXNL1 distinguish aneuploid from diploid colorectal cancers

Timo Gemoll, Uwe J. Roblick, Silke Szymczak, Till Braunschweig, Susanne Becker, Bernd Wolfgang Igl, Hans Peter Bruch, Andreas Ziegler, Ulf Hellman, Michael J. Difilippantonio, Thomas Ried, Hans Jörnvall, Gert Auer, Jens K. Habermann*

*Corresponding author for this work
10 Citations (Scopus)


DNA aneuploidy has been identified as a prognostic factor for epithelial malignancies. Further understanding of the translation of DNA aneuploidy into protein expression will help to define novel biomarkers to improve therapies and prognosis. DNA ploidy was assessed by image cytometry. Comparison of gel-electrophoresisbased protein expression patterns of three diploid and four aneuploid colorectal cancer cell lines detected 64 ploidyassociated proteins. Proteins were identified by mass spectrometry and subjected to Ingenuity Pathway Analysis resulting in two overlapping high-ranked networks maintaining Cellular Assembly and Organization, Cell Cycle, and Cellular Growth and Proliferation. CAPZA1, TXNL1, and HDAC2 were significantly validated by Western blotting in cell lines and the latter two showed expression differences also in clinical samples using a tissue microarray of normal mucosa (n = 19), diploid (n = 31), and aneuploid (n = 47) carcinomas. The results suggest that distinct protein expression patterns, affecting TXNL1 and HDAC2, distinguish aneuploid with poor prognosis from diploid colorectal cancers.

Original languageEnglish
JournalCellular and Molecular Life Sciences
Issue number19
Pages (from-to)3261-3274
Number of pages14
Publication statusPublished - 01.10.2011


Dive into the research topics of 'HDAC2 and TXNL1 distinguish aneuploid from diploid colorectal cancers'. Together they form a unique fingerprint.

Cite this